Company Applies to Legally Manufacture Heroin and Meth
Published Date: 7/23/2026
Notice
Summary
American Radiolabeled Chem wants to become a big-time maker of some powerful controlled substances, including drugs like heroin and methamphetamine. People and companies affected can share their thoughts or ask for a hearing by September 21, 2026. This move could impact drug manufacturing rules and involves careful government review, but no direct costs are mentioned yet.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-14286, Importer of Controlled Substances Application: Catalent Greenville, Inc.
Catalent Greenville, Inc. wants to become an official importer of some powerful controlled substances, including LSD and related drugs. People and companies involved with these drugs can share their thoughts or ask for a hearing by August 17, 2026. This move could impact how these substances enter the U.S., but no costs or fees are mentioned yet.
2026-14136, Barlow St-Clair Lynch, M.D.; Decision and Order
Dr. Barlow St-Clair Lynch from Maine lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means he can’t prescribe or manage controlled drugs anymore, effective immediately, impacting his medical practice and any related income.
2026-14135, David Enright, M.D.; Decision and Order
Dr. David Enright from Maine lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means he can’t prescribe or manage controlled drugs anymore, effective immediately.
2026-14137, Shane Lydon, M.D.; Decision and Order
Dr. Shane Lydon's license to handle controlled substances in Maine has been revoked because he lost his state authority and didn’t ask for a hearing. This means he can no longer prescribe or manage these drugs, effective immediately. Anyone relying on his registration should update their records and note this change to avoid legal trouble.
Previous / Next Documents
Previous: 2026-14914, Privacy Act of 1974; System of Records; Correction
The Department of Defense fixed a mistake about when a privacy record system change takes effect. Instead of August 17, 2026, the correct date is July 16, 2026. This update affects anyone tracking these privacy rules and makes sure the timeline is clear—no extra costs or delays involved!
Next: 2026-14916, Information Collection: NRC Form 313, Application for Materials License and NRC Forms 313A (Radiation Safety Officer (RSO)), 313A (AMP), 313A (Authorized Nuclear Pharmacist (ANP)), 313A (Authorized User Training, Experience and Preceptor Attestation (AUD)), 313A (Authorized User Training, Experience, and Preceptor Attestation (AUT)), and 313A (Authorized User Training, Experience and Preceptor Attestation (AUS))
The Nuclear Regulatory Commission is renewing its forms for people and businesses applying for materials licenses and radiation safety roles. If you work with radioactive materials or oversee safety, this affects you! The NRC wants your feedback by August 24, 2026, but there’s no new cost or big changes—just keeping things up to date and clear.